Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912767 · ClinicalTrials.gov registry record
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 625
- Enrollment target
NCT02912767: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02912767 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 625 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912767 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 625 participants
- Enrollment target
Study Summary
The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help them improve care for women treated for endometrial cancer.
Interventions
- BEHAVIORAL questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 625 participants |
| Start Date | 2016-07-20 |
| Est. Completion | 2020-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912767
The ClinicalTrials.gov registry entry for NCT02912767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 625 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.
NCT02912767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912767 about?
NCT02912767 is a clinical study titled "Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer". The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help...
What is the current status of trial NCT02912767?
This trial is currently completed. The enrollment target is 625 participants. The study started on 2016-07-20. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT02912767?
The interventions under investigation include: questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02912767?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.